PENTASA SUPPOSITORIES Ізраїль - англійська - Ministry of Health

pentasa suppositories

ferring pharmaceuticals ltd - mesalazine - suppositories - mesalazine 1000 mg - mesalazine - mesalazine - ulcerative proctitis.

PENTASA ENEMA Ізраїль - англійська - Ministry of Health

pentasa enema

ferring pharmaceuticals ltd - mesalazine - enema - mesalazine 1 g / 100 ml - aminosalicylic acid and similar agents - ulcerative colitis - chron's disease

ENTYVIO vedolizumab 300 mg powder for injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

entyvio vedolizumab 300 mg powder for injection vial

takeda pharmaceuticals australia pty ltd - vedolizumab, quantity: 331.2 mg - injection, powder for - excipient ingredients: polysorbate 80; arginine hydrochloride; histidine; sucrose; histidine hydrochloride monohydrate - ulcerative colitis,treatment of adult patients with moderate to severe ulcerative colitis who have had an inadequate response with, lost response to, or are intolerant to either conventional therapy or a tumour necrosis factor-alpha (tnf-alpha) antagonist.,crohn?s disease,treatment of adult patients with moderate to severe crohn?s disease who have had an inadequate response with, lost response to, or are intolerant to either conventional therapy or a tumour necrosis factor-alpha (tnf-alpha) antagonist.,pouchitis,entyvio is indicated for the treatment of adult patients with moderate to severe chronic pouchitis, who have undergone proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis, and have had an inadequate response with or lost response to antibiotic therapy.

PYRALIN EN Sulfasalazine 500mg tablet Австралія - англійська - Department of Health (Therapeutic Goods Administration)

pyralin en sulfasalazine 500mg tablet

pfizer australia pty ltd - sulfasalazine, quantity: 500 mg - tablet, enteric coated - excipient ingredients: white beeswax; propylene glycol; magnesium stearate; colloidal anhydrous silica; cellacefate; purified talc; macrogol 20000; povidone; carnauba wax; maize starch; glyceryl monostearate - ulcerative colitis and crohn's disease: adjunct in the treatment of ulcerative colitis with the usual supportive and dietary measures. for the management of severe, acute attacks of ulcerative colitis, rectal and systemic corticosteroid therapy appears to be clinically superior to sulfasalazine, but sulfasalazine may be more effective than corticosteroids in reducing the number of relapses in patients on maintenance therapy. in the treatment of active crohn's disease, especially in patients with colonic involvement. rheumatoid arthritis: pyralin en tablets are indicated for rheumatoid arthritis which has failed to respond to non-steroidal anti-inflammatory drugs (nsaids).

ENTYVIO I.V. Ізраїль - англійська - Ministry of Health

entyvio i.v.

takeda israel ltd - vedolizumab - powder for concentrate for solution for infusion - vedolizumab 300 mg/vial - vedolizumab - ulcerative colitis:entyvio is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (tnfα) antagonist.crohn’s disease:entyvio is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (tnfα) antagonist.

ASACOL 400 Ізраїль - англійська - Ministry of Health

asacol 400

tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 400 mg - mesalazine - " ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes."

ASACOL 800 Ізраїль - англійська - Ministry of Health

asacol 800

tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 800 mg - mesalazine - " ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes."

ENTYVIO S.C Ізраїль - англійська - Ministry of Health

entyvio s.c

takeda israel ltd - vedolizumab - solution for injection - vedolizumab 158.8 mg / 1 ml - vedolizumab - ulcerative colitisentyvio is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor-alpha (tnfα) antagonist.crohn’s diseaseentyvio is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor-alpha (tnfα) antagonist.

RINVOQ 45 MG Ізраїль - англійська - Ministry of Health

rinvoq 45 mg

abbvie biopharmaceuticals ltd, israel - upadacitinib as hemihydrate - tablets prolonged release - upadacitinib as hemihydrate 45 mg - upadacitinib - ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Siguent Hycor 1% Австралія - англійська - Department of Health (Therapeutic Goods Administration)

siguent hycor 1%

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - eye ointment - excipient ingredients: white soft paraffin; liquid paraffin; wool fat - inflammatory conditions of the eye, including allergic conjunctivitis, nonpurulent conjunctivitis and/or blepharitis, iritis, herpes zoster ophthalmicus, recurrent marginal ulceration.